KEYNOTE-024 6 and KEYNOTE-042 7 subgroup analyses found that immunotherapy alone significantly improved median OS compared to chemotherapy in elderly patients with PD-L1 ≥ 50% in advanced driver-negative NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.